DP
CNTB

Diadema Partners’s Connect Biopharma Holdings CNTB Stock Holding History

Diadema Partners’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$526K Buy
+200,690
New +$523K 0.09% 106

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Diadema Partners's CNTB Position: Q1 2026 in Review

Diadema Partners opened a new position in Connect Biopharma Holdings (CNTB) in Q1 2026: 200,690 shares worth $526K. The stake represents 0.09% of the portfolio and ranks #106 among its holdings.

41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • Diadema Partners held 200,690 shares of Connect Biopharma Holdings worth $526K as of Q1 2026.
  • Connect Biopharma Holdings was a new Diadema Partners position in Q1 2026.
  • Connect Biopharma Holdings made up 0.09% of Diadema Partners's portfolio in Q1 2026, its #106 holding.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Diadema Partners's 13F filing for Q1 2026, filed 15 May 2026.